Gilgamesh Pharmaceuticals
ID: 6623106Gilgamesh Pharmaceuticals is a pharmaceutical platform company developing an oral arylcyclohexylamine therapeutic and the next generation of psychedelic-related medicines.
1
Funding Rounds
$27.0m
Money raised
Recent Funding Rounds
Unlock Complete Company Intelligence
Access comprehensive data and insights available only to Seedtable members
Financial Details
- • Complete funding history and valuations
- • Revenue estimates and financial metrics
- • Investment round details and terms
People & Contacts
- • Complete leadership team profiles
- • Contact information and email addresses
- • Board members and advisors
Market Intelligence
- • Competitive landscape analysis
- • Market position and growth metrics
- • Industry benchmarking data
Premium Tools
- • Export data and generate reports
- • Save companies to custom watchlists
- • API access for data integration
Join 10,000+ Professionals
Trusted by investors, founders, and analysts worldwide
Access detailed insights on 71,000+ companies worldwide
| Name | Phone | Social networks | |
|---|---|---|---|
| Jo****** Sp*** |
|
- | |
| Da***** Sa*** |
|
- | |
| An**** Kr***** |
|
- | |
| Mi** Cu******** |
|
- | linkedin twitter |
| Je** Wi**** |
|
- | linkedin facebook |
Funding series
Funding Series Analysis
The company Gilgamesh Pharmaceuticals has raised a total of $27m in funding over 1 rounds.
Key Insights:
- Gilgamesh Pharmaceuticals Series A round, May 2021: $27m
Industries
Gilgamesh Pharmaceuticals is active in the following industries: